Comprehensive genomic access to vector integration in clinical gene therapy.
about
Retroviral integrations in gene therapy trialsBioinformatics and HIV latency.Development of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection: Considerations for Proof of Concept Studies and Translation to Standard Medical PracticeGene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?Gene therapy from the perspective of systems biology.Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles.Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.Comparing DNA integration site clusters with scan statistics.Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.Vector integration and tumorigenesis.CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient CellsSuccession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts.Analyzing the number of common integration sites of viral vectors--new methods and computer programs.Estimating abundances of retroviral insertion sites from DNA fragment length data.Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence.High-throughput, sensitive quantification of repopulating hematopoietic stem cell clones.Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors.Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA.Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.Identifying viral integration sites using SeqMap 2.0.Assessing the potential for AAV vector genotoxicity in a murine model.Lentiviral vector integration profiles differ in rodent postmitotic tissuesA combinatorial approach to the restriction of a mouse genome.Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic riskA method to sequence and quantify DNA integration for monitoring outcome in gene therapy.Contributions of gene marking to cell and gene therapies.Fanconi anemia gene editing by the CRISPR/Cas9 system.Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia.Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systemsImproving the efficiency of transposon mutagenesis in Salmonella enteritidis by overcoming host-restriction barriers.No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells.Retroviral vectors: post entry events and genomic alterations.Applications of next-generation sequencing technologies to diagnostic virology.Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditionsHigh-throughput monitoring of integration site clonality in preclinical and clinical gene therapy studies.Presence of a trs-Like Motif Promotes Rep-Mediated Wild-Type Adeno-Associated Virus Type 2 Integration.Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations.Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo.
P2860
Q26991660-847461C0-2F35-4C17-8A6D-47030DAF0F72Q28081427-5AD4A006-CEC2-47E9-B4E8-8EF418521C61Q29036869-612C279B-404D-4C70-9672-8DA2A427391AQ30364488-1BF73158-57A4-4606-ADF4-24866A49F669Q30430438-95BA37D9-954A-4168-B013-5DE9519CEB84Q30531604-15800EFC-11CC-4B9B-9579-550F2FF4AEA1Q33565359-8E8C4865-5674-472D-987C-C531A05FE819Q33586934-D8EA296B-2D14-49CA-93B6-9FD97CF9BCEAQ33641937-9D708436-9745-479C-AB7C-B40151091352Q33671980-F6CF2608-5700-4129-A806-F4E99E9C10C6Q33782783-1C1B4AE1-FC50-4AE3-B872-3E1648190DC3Q33838956-34B183B5-CDBE-4BE2-8A06-867B14333288Q33863533-BBF4D69C-00C2-4D45-95F1-048C6B8B9173Q34055417-7B4C10B3-5670-41AA-B6C7-138DB04EA31AQ34124838-7E095297-6098-44CF-A7CE-793ED27FD9ADQ34249667-CEA1CCD5-E02A-4F84-A070-1E466DFB08ECQ34296095-297F3D1D-A9C5-4D5A-BE7D-D51AC1EF3FFDQ34383023-0F62755D-46A2-43EA-8818-0030EB834B53Q34385265-CBB96593-404F-425E-916F-784860A6492DQ34449867-93AD64B0-8419-4CC3-AACB-1DF8D725CCA4Q34588579-11C728D2-D8FE-409D-9EAD-2C441E902793Q34754355-62F9F5A0-634D-4275-B4D0-981A2319A62CQ34757287-F69CCC84-39D4-452D-9A68-CC5942CB4AC1Q34856638-28056CAB-00A2-45AD-8472-4623D0633B8FQ35038004-44BF4914-C6AE-4C6E-B4AC-77DF03B9DEC1Q35041012-7C7FC141-E6E1-4E4D-AB03-CB109DA11DCEQ35059829-65A22456-15F0-4515-ACF4-09F2F869BB1FQ35077625-CE022FF6-466F-4CFE-8646-83366E29DCF5Q35086103-FF344BF4-78F1-4B1B-960F-972397893BFBQ35086128-4CC471A4-953A-4752-92A3-E14BE0CC19BAQ35110771-4A753C52-21BB-47ED-B186-5ECC4C6D437CQ35196719-350BE1D6-69DA-414B-8F10-1525F98C3522Q35215395-1532CE48-576C-4531-AA5B-9D04D0684F84Q35261336-F4ED66EF-2C7D-4E51-9765-EBB06BB88BA1Q35600172-7BD2396D-FC0D-4C54-BDFE-8B050B76D2FEQ35652683-2BE12947-1139-42D1-A83C-F9754CD658E7Q35665038-56F2C426-DB24-4A3A-AF1C-6F37CDA98EDFQ35758689-E24DFBD8-1619-42B5-AF22-3456B4A677E6Q35913748-B4796CDE-424D-4AD0-B94F-03590090CCB4Q35939411-8581BCA7-FF27-4778-B89D-5E8E0FBF8623
P2860
Comprehensive genomic access to vector integration in clinical gene therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comprehensive genomic access to vector integration in clinical gene therapy.
@en
Comprehensive genomic access to vector integration in clinical gene therapy.
@nl
type
label
Comprehensive genomic access to vector integration in clinical gene therapy.
@en
Comprehensive genomic access to vector integration in clinical gene therapy.
@nl
prefLabel
Comprehensive genomic access to vector integration in clinical gene therapy.
@en
Comprehensive genomic access to vector integration in clinical gene therapy.
@nl
P2093
P50
P356
P1433
P1476
Comprehensive genomic access to vector integration in clinical gene therapy.
@en
P2093
Ali Nowrouzi
Anna Paruzynski
Anne Arens
Annette Deichmann
Cynthia C Bartholomae
H Bobby Gaspar
Hanno Glimm
Kamaljit S Balaggan
Katrin Faber
Kerstin Schwarzwaelder
P2888
P304
P356
10.1038/NM.2057
P407
P50
P577
2009-11-22T00:00:00Z
P6179
1036099054